Lorundrostat’s Promise for Persistent Hypertension
May 01, 2025•3 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
🚀 Lorundrostat lowers 24-hour systolic BP in resistant hypertension! 🎯
🔬 Selective aldosterone synthase inhibition shows promise but watch for hyperkalemia ⚠️
🌟 New hope for tough-to-treat BP!
#Hypertension #Cardiology #NEJM
For the best experience, listen in Metacast app for iOS or Android